Tag: first generic filer
Why the First Generic Drug Filer Gets 180 Days of Market Exclusivity
The first generic drug company to file a patent challenge gets 180 days of exclusive sales rights under U.S. law. This rule, part of the Hatch-Waxman Act, drives competition but is often exploited to delay generic access.
Learn more...